HealthBanks Leadership

Our Leadership Team

HealthBanks is led by a seasoned management team who has a proven track record of success in establishing top-notch cellular banks, and running healthcare and life science technology companies.

Executive Management Team

Chris Xu

Chris Xu

PhD/MBA, Chairman

  • 20+ years in life sciences and pharmaceutical and stem cell banking industry with track records of success in business
  • Successful experiences in building and running high profile stem cell banks and life science technology companies
  • PhD in immunology from Washington University Sch of Medicine
Michelle Zhu

Michelle Zhu

President

  • 25+ years of operation experience in stem cell banking industry, helped building 10+ cord blood and stem cell banks worldwide
  • Years of stem cell research experiences at Harvard Medical School
Phil Coelho

Phil Coelho

Chief Technology Officer

  • 30+ years of C-level experience with public life science companies
  • Inventor of many of the legendary automated cellular processing products
  • Holder of 50+ US patents and 300+ international patents
Michael Holder

Michael Holder

Chief Financial Officer

  • 25+ years of financial, transactional, and operational experience.
  • Broad experience as CFO, CEO, Board Director, PE/VC Investor, and M&A professional of public and VC/PE backed Life Sciences, Healthcare, Medtech, and Technology companies.
  • MBA from Wharton School of Business.
Paul V. Holland

Paul V. Holland

MD, Chief Medical Director

  • 40+ years experiences with immunology, hematology and blood transfusion medicine
  • MD from University of California, Los Angeles, served as Chief and Directors at various public and private blood banks
Joseph Shen

Joseph Shen

MBA, Chief Marketing & Digital Officer

  • 25+ years of experiences in business consulting, sales and marketing in healthcare insurance industry, served as VP at one of the largest healthcare insurance companies in the nation
  • More than 10 years of experience as Consulting Partner at IBM for commercial healthcare sector
  • MBA from Indiana University, Kelley School of Business
Jody Patterson

Jody Patterson

Director of Quality

  • 30+ years of experience as the head of quality assurance in medical field, including serving Director of Quality at Cord Blood Registry (CBR), one of the nation’s largest cord blood banks
  • AABB certified quality inspector, FACT accreditor

Subscribe to Our Newsletter & Special Promotions

Disclaimer: The use of cord blood and immune cells is determined by the treating physician and manufacturer of the final products and is influenced by many factors, including the patient's medical condition, the characteristics of the sample, and whether the immune cells should be further modified or expanded. Cord blood has established uses in transplant medicine; however, its use in regenerative medicine is still being researched. There is no guarantee that potential medical applications being studied in the laboratory or clinical trials will become available. Cord tissue use is still in early research stages, and there is no guarantee that treatments using cord tissue will be available in the future. Cord tissue is stored whole. Additional processing prior to use will be required to extract and prepare any of the multiple cell types from cryopreserved cord tissue. Immune cells has established uses in certain blood cancer treatment; however, its use in solid cancer is still being researched. There is no guarantee that treatments being studied in the laboratory, clinical trials, or other experimental treatments will be available in the future.

HealthBanks cryopreserves immune cells that have been collected from an individual for potential future cellular therapy use. HealthBanks does not provide medical advice, treatment or care. The use of cryopreserved cells for future immunotherapies is not guaranteed. Much is yet unknown about the future of immunotherapy and the immune cells that have been cryopreserved. The use of cryopreserved cells by commercial manufacturers for CAR-T therapy production is not currently approved by the FDA. There is active research ongoing, however, there is no guarantee that your cryopreserved cells will have a future therapeutic use. Only your health care professional can help you evaluate whether your cells might be used and if so, how they might be used. HealthBanks and its shareholders, directors, officers, agents, employees, affiliates, network of providers and provider facilities, will not be liable to you or any other party for claims relating to sample collection or if your cells cannot be used, or if any harm, injury, damage or loss results from the use of your cells. For more information, please refer to HealthBanks Service Agreement.